Literature DB >> 2582413

A monoclonal antibody against human thrombospondin inhibits platelet aggregation.

V M Dixit, D M Haverstick, K M O'Rourke, S W Hennessy, G A Grant, S A Santoro, W A Frazier.   

Abstract

A monoclonal antibody (C6.7) has been generated against the calcium-replete form of human platelet thrombospondin (TSP). C6.7 is specific for TSP as determined by both competitive radioimmunoassay and immunoprecipitation. This antibody inhibits both thrombin- and A23187-induced aggregation of gel-filtered platelets in a concentration-dependent manner without affecting the secretion of serotonin. The epitope on TSP recognized by C6.7 has been localized to an 18-kDa fragment that is present in mild chymotryptic digests of TSP. This fragment is disulfide-linked to a 120- to 140-kDa fragment in unreduced digests, and both reduction and denaturation are required to separate the 18-kDa peptide from the larger fragments. A 25-kDa heparin binding domain is also present in the chymotryptic digest. However, the 18-kDa peptide is distinct from the heparin binding domain. The amino acid sequence at the NH2 terminus of the 18-kDa fragment is Asp-Thr-Asn-Pro-Thr-Arg-Ala-Gln-Gly-Tyr-.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2582413      PMCID: PMC397798          DOI: 10.1073/pnas.82.10.3472

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  39 in total

1.  Isolation and characterization of a high molecular weight glycoprotein from human blood platelets.

Authors:  J W Lawler; H S Slayter; J E Coligan
Journal:  J Biol Chem       Date:  1978-12-10       Impact factor: 5.157

2.  Inhibition of human platelet aggregation by monovalent antifibrinogen antibody fragments.

Authors:  D M Tollefsen; P W Majerus
Journal:  J Clin Invest       Date:  1975-06       Impact factor: 14.808

3.  Isolation and properties of a thrombin-sensitive protein of human platelets.

Authors:  N L Baenziger; G N Brodie; P W Majerus
Journal:  J Biol Chem       Date:  1972-05-10       Impact factor: 5.157

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Platelet plasma membrane lectin activity.

Authors:  T K Gartner; D C Williams; D R Phillips
Journal:  Biochem Biophys Res Commun       Date:  1977-11-21       Impact factor: 3.575

6.  Degradation of fibronectin by human leukocyte elastase. Release of biologically active fragments.

Authors:  J A McDonald; D G Kelley
Journal:  J Biol Chem       Date:  1980-09-25       Impact factor: 5.157

7.  Thrombin increases expression of fibronectin antigen on the platelet surface.

Authors:  M H Ginsberg; R G Painter; J Forsyth; C Birdwell; E F Plow
Journal:  Proc Natl Acad Sci U S A       Date:  1980-02       Impact factor: 11.205

8.  Localization of the hemagglutinating activity of platelet thrombospondin to a 140 000-dalton thermolytic fragment.

Authors:  D M Haverstick; V M Dixit; G A Grant; W A Frazier; S A Santoro
Journal:  Biochemistry       Date:  1984-11-06       Impact factor: 3.162

9.  Biochemical studies of two patients with the gray platelet syndrome. Selective deficiency of platelet alpha granules.

Authors:  J M Gerrard; D R Phillips; G H Rao; E F Plow; D A Walz; R Ross; L A Harker; J G White
Journal:  J Clin Invest       Date:  1980-07       Impact factor: 14.808

10.  The major cell surface glycoprotein of chick embryo fibroblasts is an agglutinin.

Authors:  K M Yamada; S S Yamada; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1975-08       Impact factor: 11.205

View more
  51 in total

Review 1.  Thrombospondin as a mediator of cancer cell adhesion in metastasis.

Authors:  D A Walz
Journal:  Cancer Metastasis Rev       Date:  1992-11       Impact factor: 9.264

2.  Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis.

Authors:  J Savill; N Hogg; Y Ren; C Haslett
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

3.  Thrombospondin expression in traumatized skeletal muscle. Correlation of appearance with post-trauma regeneration.

Authors:  S C Watkins; G W Lynch; L P Kane; H S Slayter
Journal:  Cell Tissue Res       Date:  1990-07       Impact factor: 5.249

Review 4.  CD47: a new target in cardiovascular therapy.

Authors:  Jeff S Isenberg; David D Roberts; William A Frazier
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-01-10       Impact factor: 8.311

5.  Thrombospondin-1 controls vascular platelet recruitment and thrombus adherence in mice by protecting (sub)endothelial VWF from cleavage by ADAMTS13.

Authors:  Arnaud Bonnefoy; Kim Daenens; Hendrik B Feys; Rita De Vos; Petra Vandervoort; Jos Vermylen; Jack Lawler; Marc F Hoylaerts
Journal:  Blood       Date:  2005-10-04       Impact factor: 22.113

6.  Functional behavior and gene expression of magnetic nanoparticle-loaded primary endothelial cells for targeting vascular stents.

Authors:  Fatema Tuj Zohra; Mikhail Medved; Nina Lazareva; Boris Polyak
Journal:  Nanomedicine (Lond)       Date:  2015-05       Impact factor: 5.307

7.  Thrombospondin-1 is required for normal murine pulmonary homeostasis and its absence causes pneumonia.

Authors:  J Lawler; M Sunday; V Thibert; M Duquette; E L George; H Rayburn; R O Hynes
Journal:  J Clin Invest       Date:  1998-03-01       Impact factor: 14.808

8.  Identification of a new class of inducible receptors on platelets. Thrombospondin interacts with platelets via a GPIIb-IIIa-independent mechanism.

Authors:  M L Aiken; M H Ginsberg; E F Plow
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

9.  Muskelin, a novel intracellular mediator of cell adhesive and cytoskeletal responses to thrombospondin-1.

Authors:  J C Adams; B Seed; J Lawler
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

10.  Molecular and functional differences induced in thrombospondin-1 by the single nucleotide polymorphism associated with the risk of premature, familial myocardial infarction.

Authors:  Natalya V Narizhneva; Vicky J Byers-Ward; Martin J Quinn; Frank J Zidar; Edward F Plow; Eric J Topol; Tatiana V Byzova
Journal:  J Biol Chem       Date:  2004-03-08       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.